Business · 05/04/2018Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance for Liposome Drug Products
The FDA has finalized a guidance document for industry on liposome drug products, providing recommendations for chemistry, manufacturing, and controls, pharmacokinetics and bioavailability, and labeling documentation for new and abbreviated drug applications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →